Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bayer

Showing results (351-360 of 528) with videos related to

Pageof 53
Sort By:
Chest|February 1, 1988
Tricuspid valve endocarditis due to Staphylococcus aureus. Correlation of two-dimensional echocardiography with clinical outcomeA S Bayer, I K Blomquist, E Bello, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2012
Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureusYan Q Xiong, Wessam Abdel Hady, Arnold S Bayer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2011
Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin bindingAbhay Dhand, Arnold S Bayer, Joseph Pogliano, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2010
Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanismsSoo-Jin Yang, Cynthia C Nast, Nagendra N Mishra, et al.
The Journal of Infectious Diseases|August 27, 2002
Activation and transcriptional interaction between agr RNAII and RNAIII in Staphylococcus aureus in vitro and in an experimental endocarditis modelYan-Qiong Xiong, William Van Wamel, Cynthia C Nast, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2024
NaHCO3 modulates the bla operon and β-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus (BORSA)Selvi C Ersoy, Sabrina L Madrigal, Richard A Proctor, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-Resistant <i>Staphylococcus aureus</i> BacteriolysisChiara Indiani, Karen Sauve, Assaf Raz, et al.
Infection and Immunity|November 14, 1997
Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteinsA S Bayer, M D Ramos, B E Menzies, et al.
Journal of Experimental Botany|October 10, 2017
Cutin from agro-waste as a raw material for the production of bioplasticsJosé A Heredia-Guerrero, Antonio Heredia, Eva Domínguez, et al.
The Journal of Infectious Diseases|December 18, 2008
Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis modelYan Q Xiong, Vance G Fowler, Michael R Yeaman, et al.
Pageof 53

Showing results (351-360 of 528) with videos related to

Sort By:
Pageof 53
Chest|February 1, 1988
Tricuspid valve endocarditis due to Staphylococcus aureus. Correlation of two-dimensional echocardiography with clinical outcomeA S Bayer, I K Blomquist, E Bello, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2012
Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureusYan Q Xiong, Wessam Abdel Hady, Arnold S Bayer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2011
Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin bindingAbhay Dhand, Arnold S Bayer, Joseph Pogliano, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2010
Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanismsSoo-Jin Yang, Cynthia C Nast, Nagendra N Mishra, et al.
The Journal of Infectious Diseases|August 27, 2002
Activation and transcriptional interaction between agr RNAII and RNAIII in Staphylococcus aureus in vitro and in an experimental endocarditis modelYan-Qiong Xiong, William Van Wamel, Cynthia C Nast, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2024
NaHCO3 modulates the bla operon and β-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus (BORSA)Selvi C Ersoy, Sabrina L Madrigal, Richard A Proctor, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-Resistant <i>Staphylococcus aureus</i> BacteriolysisChiara Indiani, Karen Sauve, Assaf Raz, et al.
Infection and Immunity|November 14, 1997
Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteinsA S Bayer, M D Ramos, B E Menzies, et al.
Journal of Experimental Botany|October 10, 2017
Cutin from agro-waste as a raw material for the production of bioplasticsJosé A Heredia-Guerrero, Antonio Heredia, Eva Domínguez, et al.
The Journal of Infectious Diseases|December 18, 2008
Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis modelYan Q Xiong, Vance G Fowler, Michael R Yeaman, et al.
Pageof 53